LRP in amyloid-β production and metabolism

Guojun D Bu, Judy Cam, Celina Zerbinatti

Research output: Chapter in Book/Report/Conference proceedingConference contribution

99 Citations (Scopus)

Abstract

Amyloid-β peptide (Aβ) production and accumulation in the brain is a central event in the pathogenesis of Alzheimer's disease (AD). Recent studies have shown that apolipoprotein E (apoE) receptors, members of the low-density lipoprotein receptor (LDLR) family, modulate Aβ production as well as Aβ cellular uptake. Aβ is derived from proteolytic processing of the amyloid precursor protein (APP), which interacts with several members of the LDLR family. Studies from our laboratory have focused on two members of the LDLR family, the LDLR-related protein (LRP) and LRP1B. Our in vitro studies have shown that while LRP's rapid endocytosis facilitates APP endocytic trafficking and processing to Aβ, LRP1B's slow endocytosis inhibits these processes. In addition to modulating APP endocytic trafficking, LRP's rapid endocytosis also facilitates Aβ cellular uptake by binding to Aβ either directly or via LRP ligands such as apoE. Our in vivo studies using transgenic mice have shown that overexpression of LRP in central nervous system (CNS) neurons increases soluble brain Aβ and this increase correlates with deficits in memory.Together our studies demonstrate that members of the LDLR family modulate APP processing and Aβ metabolism by several independent mechanisms. Understanding the pathways that modulate brain Aβ metabolismmay enable the rational design of molecular medicine to treat AD.

Original languageEnglish (US)
Title of host publicationAnnals of the New York Academy of Sciences
Pages35-53
Number of pages19
Volume1086
DOIs
StatePublished - Nov 2006
Externally publishedYes

Publication series

NameAnnals of the New York Academy of Sciences
Volume1086
ISSN (Print)00778923
ISSN (Electronic)17496632

Fingerprint

Amyloidogenic Proteins
LDL Receptors
Amyloid
Metabolism
Amyloid beta-Protein Precursor
Endocytosis
Brain
Protein Transport
Proteins
Alzheimer Disease
Processing
LDL-Receptor Related Proteins
Low Density Lipoprotein Receptor-Related Protein-1
Molecular Medicine
Serum Amyloid A Protein
Memory Disorders
Neurology
Apolipoproteins E
Transgenic Mice
Neurons

Keywords

  • Alzheimer's disease
  • APP
  • LDL receptor
  • LRP
  • LRP1B

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Bu, G. D., Cam, J., & Zerbinatti, C. (2006). LRP in amyloid-β production and metabolism. In Annals of the New York Academy of Sciences (Vol. 1086, pp. 35-53). (Annals of the New York Academy of Sciences; Vol. 1086). https://doi.org/10.1196/annals.1377.005

LRP in amyloid-β production and metabolism. / Bu, Guojun D; Cam, Judy; Zerbinatti, Celina.

Annals of the New York Academy of Sciences. Vol. 1086 2006. p. 35-53 (Annals of the New York Academy of Sciences; Vol. 1086).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Bu, GD, Cam, J & Zerbinatti, C 2006, LRP in amyloid-β production and metabolism. in Annals of the New York Academy of Sciences. vol. 1086, Annals of the New York Academy of Sciences, vol. 1086, pp. 35-53. https://doi.org/10.1196/annals.1377.005
Bu GD, Cam J, Zerbinatti C. LRP in amyloid-β production and metabolism. In Annals of the New York Academy of Sciences. Vol. 1086. 2006. p. 35-53. (Annals of the New York Academy of Sciences). https://doi.org/10.1196/annals.1377.005
Bu, Guojun D ; Cam, Judy ; Zerbinatti, Celina. / LRP in amyloid-β production and metabolism. Annals of the New York Academy of Sciences. Vol. 1086 2006. pp. 35-53 (Annals of the New York Academy of Sciences).
@inproceedings{9672b25c957c4acea5577918f1b78cb5,
title = "LRP in amyloid-β production and metabolism",
abstract = "Amyloid-β peptide (Aβ) production and accumulation in the brain is a central event in the pathogenesis of Alzheimer's disease (AD). Recent studies have shown that apolipoprotein E (apoE) receptors, members of the low-density lipoprotein receptor (LDLR) family, modulate Aβ production as well as Aβ cellular uptake. Aβ is derived from proteolytic processing of the amyloid precursor protein (APP), which interacts with several members of the LDLR family. Studies from our laboratory have focused on two members of the LDLR family, the LDLR-related protein (LRP) and LRP1B. Our in vitro studies have shown that while LRP's rapid endocytosis facilitates APP endocytic trafficking and processing to Aβ, LRP1B's slow endocytosis inhibits these processes. In addition to modulating APP endocytic trafficking, LRP's rapid endocytosis also facilitates Aβ cellular uptake by binding to Aβ either directly or via LRP ligands such as apoE. Our in vivo studies using transgenic mice have shown that overexpression of LRP in central nervous system (CNS) neurons increases soluble brain Aβ and this increase correlates with deficits in memory.Together our studies demonstrate that members of the LDLR family modulate APP processing and Aβ metabolism by several independent mechanisms. Understanding the pathways that modulate brain Aβ metabolismmay enable the rational design of molecular medicine to treat AD.",
keywords = "Aβ, Alzheimer's disease, APP, LDL receptor, LRP, LRP1B",
author = "Bu, {Guojun D} and Judy Cam and Celina Zerbinatti",
year = "2006",
month = "11",
doi = "10.1196/annals.1377.005",
language = "English (US)",
isbn = "1573316555",
volume = "1086",
series = "Annals of the New York Academy of Sciences",
pages = "35--53",
booktitle = "Annals of the New York Academy of Sciences",

}

TY - GEN

T1 - LRP in amyloid-β production and metabolism

AU - Bu, Guojun D

AU - Cam, Judy

AU - Zerbinatti, Celina

PY - 2006/11

Y1 - 2006/11

N2 - Amyloid-β peptide (Aβ) production and accumulation in the brain is a central event in the pathogenesis of Alzheimer's disease (AD). Recent studies have shown that apolipoprotein E (apoE) receptors, members of the low-density lipoprotein receptor (LDLR) family, modulate Aβ production as well as Aβ cellular uptake. Aβ is derived from proteolytic processing of the amyloid precursor protein (APP), which interacts with several members of the LDLR family. Studies from our laboratory have focused on two members of the LDLR family, the LDLR-related protein (LRP) and LRP1B. Our in vitro studies have shown that while LRP's rapid endocytosis facilitates APP endocytic trafficking and processing to Aβ, LRP1B's slow endocytosis inhibits these processes. In addition to modulating APP endocytic trafficking, LRP's rapid endocytosis also facilitates Aβ cellular uptake by binding to Aβ either directly or via LRP ligands such as apoE. Our in vivo studies using transgenic mice have shown that overexpression of LRP in central nervous system (CNS) neurons increases soluble brain Aβ and this increase correlates with deficits in memory.Together our studies demonstrate that members of the LDLR family modulate APP processing and Aβ metabolism by several independent mechanisms. Understanding the pathways that modulate brain Aβ metabolismmay enable the rational design of molecular medicine to treat AD.

AB - Amyloid-β peptide (Aβ) production and accumulation in the brain is a central event in the pathogenesis of Alzheimer's disease (AD). Recent studies have shown that apolipoprotein E (apoE) receptors, members of the low-density lipoprotein receptor (LDLR) family, modulate Aβ production as well as Aβ cellular uptake. Aβ is derived from proteolytic processing of the amyloid precursor protein (APP), which interacts with several members of the LDLR family. Studies from our laboratory have focused on two members of the LDLR family, the LDLR-related protein (LRP) and LRP1B. Our in vitro studies have shown that while LRP's rapid endocytosis facilitates APP endocytic trafficking and processing to Aβ, LRP1B's slow endocytosis inhibits these processes. In addition to modulating APP endocytic trafficking, LRP's rapid endocytosis also facilitates Aβ cellular uptake by binding to Aβ either directly or via LRP ligands such as apoE. Our in vivo studies using transgenic mice have shown that overexpression of LRP in central nervous system (CNS) neurons increases soluble brain Aβ and this increase correlates with deficits in memory.Together our studies demonstrate that members of the LDLR family modulate APP processing and Aβ metabolism by several independent mechanisms. Understanding the pathways that modulate brain Aβ metabolismmay enable the rational design of molecular medicine to treat AD.

KW - Aβ

KW - Alzheimer's disease

KW - APP

KW - LDL receptor

KW - LRP

KW - LRP1B

UR - http://www.scopus.com/inward/record.url?scp=34250811784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250811784&partnerID=8YFLogxK

U2 - 10.1196/annals.1377.005

DO - 10.1196/annals.1377.005

M3 - Conference contribution

C2 - 17185504

AN - SCOPUS:34250811784

SN - 1573316555

SN - 9781573316552

VL - 1086

T3 - Annals of the New York Academy of Sciences

SP - 35

EP - 53

BT - Annals of the New York Academy of Sciences

ER -